GPER1 levels were found to be increased in drug-naïve patients with generalized anxiety disorder.
GPER1 levels showed a positive correlation with the Hamilton Anxiety Scale scores of patients.
GPER1 might be a candidate peripheral biomarker for generalized anxiety disorder.